Czechia· CZ-0149034
SYNFLORIX
A pneumokokken, gereinigtes polysaccharid-antigen und haemophilus influenzae b, konjugiert product containing streptococcus pneumoniae serotype 1 polysaccharide + streptococcus pneumoniae serotype 4 polysaccharide + streptococcus pneumoniae serotype 5 polysaccharide + streptococcus pneumoniae serotype 6b polysaccharide + 6 more, registered in Czechia by GlaxoSmithKline Biologicals S.A., Rixensart. The same ATC class is registered in 8 of our 19 countries.
Checked against SÚKL (Czech Republic) on
Informational only — not a medical device.
Where it is registered
Pneumokokken, gereinigtes polysaccharid-antigen und haemophilus influenzae b, konjugiert is registered in 8 of 19 countries.
Countries holding a registration under ATC J07AL52 (pneumokokken, gereinigtes polysaccharid-antigen und haemophilus influenzae b, konjugiert), each read from that country’s own register.
- This record: Czechia, from SÚKL (Czech Republic)
- 5 of them publish a price we can compare per daily dose
Pneumokokken, gereinigtes polysaccharid-antigen und haemophilus influenzae b, konjugiert · ATC J07AL52
8 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
The record
At a glance
SÚKL (Czech Republic)- Active substance
- STREPTOCOCCUS PNEUMONIAE SEROTYPE 1 POLYSACCHARIDE + STREPTOCOCCUS PNEUMONIAE SEROTYPE 4 POLYSACCHARIDE + STREPTOCOCCUS PNEUMONIAE SEROTYPE 5 POLYSACCHARIDE + STREPTOCOCCUS PNEUMONIAE SEROTYPE 6B POLYSACCHARIDE + 6 more
- Manufacturer
- GlaxoSmithKline Biologicals S.A., Rixensart
- Country
- Czechia (CZ)
- ATC code
- J07AL52
- ATC class
- Pneumokokken, gereinigtes Polysaccharid-Antigen und Haemophilus influenzae B, konjugiert
- Reimbursed
- Not published by this register
- Source register
- SÚKL (Czech Republic)
- Last checked
- September 28, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under J07AL52
Pneumokokken, gereinigtes polysaccharid-antigen und haemophilus influenzae b, konjugiert, as other registers publish it.
- DenmarkSynflorixGlaxoSmithKline Biologicals S.A.
- BelgiumSynflorixGlaxoSmithKline Biologicals
- BelgiumSynflorixGlaxoSmithKline Biologicals
- BelgiumSynflorixGlaxoSmithKline Biologicals
- FinlandSynflorixGlaxoSmithKline Biologicals SA
- FinlandSynflorixGlaxoSmithKline Biologicals SA
- PolandSynflorixGlaxoSmithKline Biologicals S.A.
- IcelandSynflorixGlaxoSmithKline Biologicals S.A.*
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f03a121c-55b9-4637-897c-2e43f019c5dd GET /v1/drugs/f03a121c-55b9-4637-897c-2e43f019c5dd?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "INJ SUS ISP",
"source": "sukl",
"strength": null,
"pack_size": "1X0,5ML+1J",
"substance": "STREPTOCOCCUS PNEUMONIAE SEROTYPE 1 POLYSACCHARIDE + STREPTOCOCCUS PNEUMONIAE SEROTYPE 4 POLYSACCHARIDE + STREPTOCOCCUS PNEUMONIAE SEROTYPE 5 POLYSACCHARIDE + STREPTOCOCCUS PNEUMONIAE SEROTYPE 6B POLYSACCHARIDE + 6 more",
"cz_kod_sukl": "0149034",
"product_type": "IM",
"substance_codes": "18524,16707,18525,16708,18526,16709,16710,16711,16712,16713",
"registration_state": "R",
"registration_number": "EU/1/09/508/003"
}See everything about pneumokokken, gereinigtes polysaccharid-antigen und haemophilus influenzae b, konjugiert.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.